Analysis
of Subjects With Specific Adverse Events |
||||||
|
Placebo |
Drug High Dose |
Drug Low Dose |
|||
|
n |
(%) |
n |
(%) |
n |
(%) |
APPLICATION SITE PRURITUS |
6 |
8.7 |
22 |
27.85 |
22 |
28.57 |
DIARRHOEA |
9 |
13.04 |
0 |
0 |
0 |
0 |
ERYTHEMA |
9 |
13.04 |
14 |
17.72 |
15 |
19.48 |
HEADACHE |
7 |
10.14 |
6 |
7.59 |
0 |
0 |
PRURITUS |
8 |
11.59 |
26 |
32.91 |
23 |
29.87 |
UPPER RESPIRATORY TRACT INFECTION |
6 |
8.7 |
0 |
0 |
0 |
0 |
APPLICATION SITE DERMATITIS |
0 |
0 |
7 |
8.86 |
9 |
11.69 |
APPLICATION SITE ERYTHEMA |
0 |
0 |
15 |
18.99 |
12 |
15.58 |
APPLICATION SITE IRRITATION |
0 |
0 |
9 |
11.39 |
9 |
11.69 |
APPLICATION SITE VESICLES |
0 |
0 |
6 |
7.59 |
0 |
0 |
DIZZINESS |
0 |
0 |
12 |
15.19 |
8 |
10.39 |
HYPERHIDROSIS |
0 |
0 |
8 |
10.13 |
0 |
0 |
NASOPHARYNGITIS |
0 |
0 |
6 |
7.59 |
0 |
0 |
NAUSEA |
0 |
0 |
6 |
7.59 |
0 |
0 |
RASH |
0 |
0 |
11 |
13.92 |
13 |
16.88 |
SINUS BRADYCARDIA |
0 |
0 |
8 |
10.13 |
7 |
9.09 |
VOMITING |
0 |
0 |
7 |
8.86 |
0 |
0 |
COUGH |
0 |
0 |
0 |
0 |
6 |
7.79 |
SKIN IRRITATION |
0 |
0 |
0 |
0 |
6 |
7.79 |
†This
is footnote 1 |
||||||
Source: xxx |
||||||